(WSVN) - ATLANTA (WSVN) — A CDC advisory panel has scheduled a vote for Thursday on whether to recommend the use of a new COVID-19 booster tailored against the Omicron variant.
The so-called “bi-valent vaccines” include both the currently dominant ba-4 and ba-5 Omicron subvariants and the original version of the virus.
A yes vote for Pfizer and Moderna would likely pave the way for a rollout of the shot, possibly as soon as next week.
Copyright 2025 Sunbeam Television Corp. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.